Post-COVID-19 and the Brain
A special issue of Brain Sciences (ISSN 2076-3425). This special issue belongs to the section "Neurotechnology and Neuroimaging".
Deadline for manuscript submissions: closed (10 October 2022) | Viewed by 337
Special Issue Editor
Interests: brain injury; non-invasive brain stimulation; neuroimaging; fatigue; neurological disorders
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Post-COVID syndrome is increasingly recognized as a new clinical entity in the context of SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) infection. The WHO defines post-COVID-19 as a condition that occurs in individuals with a history of probable or confirmed SARS-CoV-2 infection, usually 3 months from the onset of COVID-19, with symptoms that last for at least 2 months and cannot be explained by an alternative diagnosis.
Scientific evidence regarding the persistence of neurological symptoms following acute COVID-19 is increasing. It is a process recently termed Neuro-PASC (neurological manifestations of post-acute sequelae of SARS-CoV-2 infection). Numerous COVID-19 patients suffer from PASC, with the number of cases rapidly increasing as more people are infected. However, it is still unclear how SARS-CoV-2 results in pathological changes in the brain.
This Special Issue aims to present cutting-edge studies of brain function in people with Post-Covid-19. In order to provide a comprehensive perspective, we welcome original research papers and review papers describing the use of the latest neuroimaging approaches including positron emission tomography (PET) and magnetic resonance imaging (MRI) in people with Post-Covid-19. Moreover, we invite papers evaluating alterations in motor and cognitive function. This Special Issue will provide innovative investigations to understand the underlying pathogenetic mechanisms of post-COVID syndrome, which is essential to inform evidence-based therapeutic management and guide future research.
Dr. Thorsten Rudroff
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Brain Sciences is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- COVID-19
- positron emission tomography
- MRI
- brain imaging
- brain metabolism
